About Intellectual Property IP Training Respect for IP IP Outreach IP for… IP and... IP in... Patent & Technology Information Trademark Information Industrial Design Information Geographical Indication Information Plant Variety Information (UPOV) IP Laws, Treaties & Judgments IP Resources IP Reports Patent Protection Trademark Protection Industrial Design Protection Geographical Indication Protection Plant Variety Protection (UPOV) IP Dispute Resolution IP Office Business Solutions Paying for IP Services Negotiation & Decision-Making Development Cooperation Innovation Support Public-Private Partnerships AI Tools & Services The Organization Working with WIPO Accountability Patents Trademarks Industrial Designs Geographical Indications Copyright Trade Secrets WIPO Academy Workshops & Seminars IP Enforcement WIPO ALERT Raising Awareness World IP Day WIPO Magazine Case Studies & Success Stories IP News WIPO Awards Business Universities Indigenous Peoples Judiciaries Genetic Resources, Traditional Knowledge and Traditional Cultural Expressions Economics Finance Intangible Assets Gender Equality Global Health Climate Change Competition Policy Sustainable Development Goals Frontier Technologies Mobile Applications Sports Tourism PATENTSCOPE Patent Analytics International Patent Classification ARDI – Research for Innovation ASPI – Specialized Patent Information Global Brand Database Madrid Monitor Article 6ter Express Database Nice Classification Vienna Classification Global Design Database International Designs Bulletin Hague Express Database Locarno Classification Lisbon Express Database Global Brand Database for GIs PLUTO Plant Variety Database GENIE Database WIPO-Administered Treaties WIPO Lex - IP Laws, Treaties & Judgments WIPO Standards IP Statistics WIPO Pearl (Terminology) WIPO Publications Country IP Profiles WIPO Knowledge Center WIPO Technology Trends Global Innovation Index World Intellectual Property Report PCT – The International Patent System ePCT Budapest – The International Microorganism Deposit System Madrid – The International Trademark System eMadrid Article 6ter (armorial bearings, flags, state emblems) Hague – The International Design System eHague Lisbon – The International System of Appellations of Origin and Geographical Indications eLisbon UPOV PRISMA UPOV e-PVP Administration UPOV e-PVP DUS Exchange Mediation Arbitration Expert Determination Domain Name Disputes Centralized Access to Search and Examination (CASE) Digital Access Service (DAS) WIPO Pay Current Account at WIPO WIPO Assemblies Standing Committees Calendar of Meetings WIPO Webcast WIPO Official Documents Development Agenda Technical Assistance IP Training Institutions COVID-19 Support National IP Strategies Policy & Legislative Advice Cooperation Hub Technology and Innovation Support Centers (TISC) Technology Transfer Inventor Assistance Program WIPO GREEN WIPO's Pat-INFORMED Accessible Books Consortium WIPO for Creators WIPO Translate Speech-to-Text Classification Assistant Member States Observers Director General Activities by Unit External Offices Job Vacancies Procurement Results & Budget Financial Reporting Oversight
Arabic English Spanish French Russian Chinese
Laws Treaties Judgments Browse By Jurisdiction

Federal Act of March 18, 2016, on Amendments to the Federal Act of December 15, 2000, on Medicines and Medical Devices, Switzerland

Latest Version in WIPO Lex
Details Details Year of Version 2019 Dates Adopted: March 18, 2016 Type of Text Other Texts Subject Matter Patents (Inventions) Subject Matter (secondary) Other Notes Paragraph 2 under Chapter III of the Federal Act of March 18, 2016, on Amendments to the Federal Act of December 15, 2000, on Medicines and Medical Devices ("Therapeutic Products Act, TPA") (hereinafter the "Amendment Act of March 18, 2016") provides that the Federal Council sets the date of entry into force of the said Amendment Act, which is indicated in section "Expiry of the referendum period and entry into force" found on page 31, as follows: - Article 9, paragraph 2, letter f; Articles 64a and 67a under Chaper I of the Amendment Act entered into force on January 1, 2018. - The remaining provisions shall come into force at a later date. On September 21, 2018, the entry into force of the remaining provisions are specified below in the "Order of September 21, 2018, Giving Partial Effect to the Amendment Act of March 18, 2016 of the Therapeutic Products Act (TPA)" : 1. The Amendment Act of March 18, 2016 that amends TPA entered into force on January 1, 2019, subject to the following paragraphs 2 and 3. (Except for Article 9, paragraph 2, letter f; Articles 64a and 67a under Chaper I of the Amendment Act as indicated in the footnote 1 of this Order). 2. Article 26, paragraph 2bis, letter a, and Article 30 of TPA (as referred to in Chapter I of the Amendment Act) entered into force on January 1, 2020. 3. Articles 33, 55, 56, 82, point 1, 86, paragraph 1, letter h of TPA; Article 49, paragraphs 1 and 3 of the Act of October 8, 2004 on Transplantation (as referred to in Chapter II. 3. in the Annex of the Amendment Act of March 18, 2016) and Amendments to the Federal Act of March 18, 1994, on Health Insurance (as referred to in Chapter II. 4. in the Annex of the Amendment Act of March 18, 2016) shall come into force at a later date.

Available Materials

Main Text(s) Related Text(s)
Main text(s) Main text(s) French Loi fédérale du 18 mars 2016 portant modification de la loi fédérale du 15 décembre 2000 sur les médicaments et les dispositifs médicaux         Italian Legge federale del 18 marzo 2016 che modifica la legge federale del 15 dicembre 2000 sui medicamenti e i dispositivi medici         German Bundesgesetz vom 18. März 2016 über Änderung über Bundesgesetz vom 15. Dezember 2000 über Arzneimittel und Medizinprodukte        
 
Download PDF open_in_new

WIPO Lex No. CH421